Galderma Group AG: Acne Vulgaris trials

The registry lists 52 Acne Vulgaris studies with Galderma Group AG as lead sponsor. 0 are open to participants now and 42 have results posted.

Phase 1 1Phase 2 6Phase 3 20Phase 4 22No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AkLief Evaluation in Acne-induced Post-Inflammatory HyperpigmentationCompletedNCT05089708Phase 4Results posted
• Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar FormationCompletedNCT04856904Phase 4Results posted
• A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)CompletedNCT04451330Phase 4Results posted
• Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne VulgarisCompletedNCT03915860Phase 3Results posted
• Efficacy and Safety of CD5024 1% in Acne VulgarisCompletedNCT03034460Phase 2Results posted
• Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin AcneCompletedNCT02932267Phase 3Results posted
• A Treatment for Severe Inflammatory Acne SubjectsCompletedNCT02899000Phase 4Results posted
• A Clinical Trial to Evaluate the Efficacy of Two Acne TreatmentsCompletedNCT02755545Phase 4Results posted
• Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne ScarsCompletedNCT02735421Phase 4Results posted
• Benzac 5% Gel in Combination With Cosmetic Products in Acne VulgarisCompletedNCT02589405Phase 4Results posted
• Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne VulgarisCompletedNCT02566369Phase 3Results posted
• Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne VulgarisCompletedNCT02556788Phase 3Results posted
• Patient Education in Adherence on Acne (PEAce)CompletedNCT02307266Phase 4Results posted
• A Treatment Regimen for Student Athletes With Mild to Moderate Acne VulgarisCompletedNCT02249104Phase 4Results posted
• CD5789 (Trifarotene) Long Term Safety Study on Acne VulgarisCompletedNCT02189629Phase 3Results posted
• Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.CompletedNCT02073461Phase 2Results posted
• Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.CompletedNCT02073448Phase 3Results posted
• Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne VulgarisCompletedNCT01951417Phase 4Results posted
• A Long Term Study of GK530G in Subjects With Acne VulgarisCompletedNCT01910064Phase 3Results posted
• Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.CompletedNCT01909713Phase 4Results posted
• Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne VulgarisCompletedNCT01880320Phase 3Results posted
• An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital LidocaineCompletedNCT01807455Phase 4Results posted
• Dose Range Study of CD5789 in Acne VulgarisCompletedNCT01616654Phase 2Results posted
• Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin GelCompletedNCT01522456Phase 4Results posted
• Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe AcneCompletedNCT01474590Phase 3Results posted
• Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne VulgarisCompletedNCT01320033Phase 2Results posted
• Adapalene Gel 0.3% in the Treatment of Atrophic Acne ScarsCompletedNCT01213199Phase 2Results posted
• Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne VulgarisCompletedNCT01209949Phase 4Results posted
• Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% GelCompletedNCT01188538Phase 4Results posted
• Epiduo Pediatric Acne StudyCompletedNCT01138735Phase 4Results posted
• Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne VulgarisCompletedNCT01014689Phase 3Results posted
• Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)AcnesCompletedNCT00907101Phase 4Results posted
• Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne VulgarisCompletedNCT00883233Phase 3Results posted
• Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne VulgarisCompletedNCT00688064Phase 3Results posted
• Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month MaintenanceCompletedNCT00687908Phase 3Results posted
• Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne VulgarisCompletedNCT00671749Phase 4Results posted
• Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%CompletedNCT00660985Phase 4Results posted
• Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%CompletedNCT00599521Phase 3Results posted
• Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%CompletedNCT00598832Phase 3Results posted
• Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris SubjectsCompletedNCT00446043Phase 3Results posted
• Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne VulgarisCompletedNCT00422240Phase 3Results posted
• A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne VulgarisCompletedNCT00421993Phase 3Results posted
• A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne VulgarisActive, not recruitingNCT07186413Phase 3
• Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory AcneCompletedNCT02338544
• A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne PatientsCompletedNCT01688531Phase 1
• Long-term Study of Epiduo in Patients With Moderate to Severe AcneCompletedNCT01618773
• Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory AcneCompletedNCT01220102
• Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne VulgarisCompletedNCT01149330Phase 4
• Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With AcneCompletedNCT01106807Phase 2
• Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of AcneCompletedNCT00469755Phase 4
• Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne VulgarisCompletedNCT00441415Phase 3
• Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%CompletedNCT00437151Phase 4